University Of Western Australia
Plozasiran lowers triglycerides, reduces pancreatitis risk in chylomicronemia
In patients with persistent chylomicronemia, plozasiran, a small interfering RNA therapy, was associated with lower triglyceride levels and reduced risk for pancreatitis, researchers reported at the European Society of Cardiology Congress.
Patients hospitalized with lupus more likely to develop, die from cancer
Patients who have been hospitalized with systemic lupus erythematous demonstrate an increased risk for multiple cancer subtypes, as well as an increased risk for 5-year mortality after cancer development, according to data.
BP reduced out to 9 years after renal denervation for resistant hypertension
There was a sustained reduction in ambulatory BP out to 9 years in patients who underwent renal denervation for resistant hypertension, according to a study published in Hypertension.
Dual endothelin receptor antagonist yields sustained BP lowering in resistant hypertension
CHICAGO — Aprocitentan, a dual endothelin antagonist, was superior to placebo for BP lowering and was well tolerated in patients with resistant hypertension, according to results of the PRECISION trial.
High levels of bone turnover markers increase risk for all-cause mortality in older men
Older men with higher concentrations of three bone turnover markers have a higher risk for all-cause mortality than those with lower concentrations, according to study findings published in the Journal of Bone and Mineral Research.
Exercise at higher elevation linked to larger drop in glucose with type 1 diabetes
People with type 1 diabetes may experience a greater decline in blood glucose when exercising at high altitudes compared with sea level, according to a study published in the Journal of Clinical Endocrinology & Metabolism.